Literature DB >> 8027975

Organometallic anticancer agents: the effect of the central metal and halide ligands on the interaction of metallocene dihalides Cp2MX2 with nucleic acid constituents.

J H Murray1, M M Harding.   

Abstract

The interactions of the metallocene dihalides Cp2MX2 (M = Ti, Mo, Zr, Hf) and Cp2TiX2 (X = F, Cl, Br, I) and the nucleic acid building blocks D-ribose-5'-phosphate, nucleobases, nucleosides, and nucleotides have been studied by 1H and 31P NMR spectroscopy. In the series Cp2TiX2 (X = F, Cl, Br, I), similar 1H NMR spectra were obtained in titrations of each metallocene with the four nucleotides. The spectra are consistent with dissociation of the halide ligands to give Cp2-Ti2+(aq), which coordinates to nucleobase (N) and phosphate (O) binding sites. The metal center (Ti, Mo, Zr, Hf) strongly influences the nature and extent of interactions between metallocene dichlorides Cp2MCl2 and DNA subunits. Immediate complexation occurs between nucleotides and the antitumor active metallocenes Cp2MX2 (M = Ti and Mo, 0.25-1.0 equiv). In contrast, formation of discrete complexes between nucleotides and the biologically inactive metallocenes Cp2MCl2 (M = Hf, Zr, 0.25-1.00) is not observed, and instead hydrolysis of the Cp rings to give free cyclopentadiene is the major reaction pathway. The complexes formed between titanocene dihalides and nucleotides are stable for hours at pH 2-5; at higher pH the binding is significantly weakened. These results are in agreement with the observed antitumor properties of the metallocene dihalides and provide support for the hypothesis that DNA-metallocene interactions are a major determinant in the antitumor properties of this class of compounds.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8027975     DOI: 10.1021/jm00039a005

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Titanocene-phosphine derivatives as precursors to cytotoxic heterometallic TiAu2 and TiM (M = Pd, Pt) compounds. Studies of their interactions with DNA.

Authors:  Jose F González-Pantoja; Michael Stern; Andrzej A Jarzecki; Eva Royo; Elisa Robles-Escajeda; Armando Varela-Ramírez; Renato J Aguilera; María Contel
Journal:  Inorg Chem       Date:  2011-09-29       Impact factor: 5.165

2.  Antitumor activity of titanocene amino acid complexes.

Authors:  P Köpf-Maier; I C Tornieporth-Oetting
Journal:  Biometals       Date:  1996-07       Impact factor: 2.949

3.  Specific Interactions of Antitumor Metallocenes with Deoxydinucleoside Monophosphates.

Authors:  Rahel P Eberle; Yvonne Hari; Stefan Schürch
Journal:  J Am Soc Mass Spectrom       Date:  2017-05-12       Impact factor: 3.109

4.  Anticancer activity and mode of action of titanocene C.

Authors:  Ulrike Olszewski; James Claffey; Megan Hogan; Matthias Tacke; Robert Zeillinger; Patrick J Bednarski; Gerhard Hamilton
Journal:  Invest New Drugs       Date:  2010-02-17       Impact factor: 3.850

5.  Interaction of metallocene dichlorides with apo-human transferrin: A spectroscopic study and cytotoxic activity against human cancer cell lines.

Authors:  Jorge R Güette Fernández; Xiomara Narváez Pita; Enrique Meléndez; Elsie I Parés Matos
Journal:  Int J Mol Biol (Edmond)       Date:  2020-07-31

6.  Exploring titanium(IV) chemical proximity to iron(III) to elucidate a function for Ti(IV) in the human body.

Authors:  Manoj Saxena; Sergio A Loza-Rosas; Kavita Gaur; Shweta Sharma; Sofia C Pérez Otero; Arthur D Tinoco
Journal:  Coord Chem Rev       Date:  2018-03-20       Impact factor: 22.315

7.  A proposed mechanism for the inhibitory effect of the anticancer agent titanocene dichloride on tumour gelatinases and other proteolytic enzymes.

Authors:  Maria Pavlaki; Katerina Debeli; Irene-Eva Triantaphyllidou; Nikolaos Klouras; Eleftheria Giannopoulou; Alexios J Aletras
Journal:  J Biol Inorg Chem       Date:  2009-04-24       Impact factor: 3.358

8.  Are cucurbiturils better drug carriers for bent metallocenes? Insights from theory.

Authors:  Dhurairajan Senthilnathan; Rajadurai Vijay Solomon; Shanmugam Kiruthika; Ponnambalam Venuvanalingam; Mahesh Sundararajan
Journal:  J Biol Inorg Chem       Date:  2018-03-03       Impact factor: 3.358

Review 9.  Organometallic anticancer compounds.

Authors:  Gilles Gasser; Ingo Ott; Nils Metzler-Nolte
Journal:  J Med Chem       Date:  2010-11-15       Impact factor: 7.446

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.